International experience of vedolizumab in primary sclerosing cholangitis and inflammatory bowel disease

Autor:	Williamson, K, Lytvyak, E, De Krijger, M, Trivedi, P, Estes, D, Yu, L, Pratt, D, De Vries, A, Daretti, L, Liu, C, Bowlus, C, Marschall, H, Montano-Loza, A, Chapman, R, Van Der Woude, C, Marzioni, M, Keshav, S, Ponsioen, C, Hirschfield, G, Levy, C
Rok vydání:	2019
DOI:	10.1016/s0016-5085(18)33652-7
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______1064::07c74b464d4f630e5dc908a576f91b0b https://doi.org/10.1016/s0016-5085(18)33652-7 Zobrazit plný text záznamu